SBI Securities Co. Ltd. Sells 3,696 Shares of Astera Labs, Inc. $ALAB

SBI Securities Co. Ltd. trimmed its position in Astera Labs, Inc. (NASDAQ:ALAB) by 20.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,540 shares of the company’s stock after selling 3,696 shares during the period. SBI Securities Co. Ltd.’s holdings in Astera Labs were worth $2,847,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Sumitomo Mitsui Trust Group Inc. raised its stake in Astera Labs by 21.6% during the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock valued at $1,336,000 after buying an additional 2,624 shares during the last quarter. Maryland State Retirement & Pension System increased its holdings in shares of Astera Labs by 37.7% during the second quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock valued at $629,000 after acquiring an additional 1,906 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of Astera Labs by 94.6% in the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock worth $9,908,000 after purchasing an additional 53,276 shares during the last quarter. Vanguard Personalized Indexing Management LLC boosted its stake in Astera Labs by 142.4% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 11,366 shares of the company’s stock worth $1,028,000 after purchasing an additional 6,677 shares in the last quarter. Finally, Harbour Investments Inc. grew its position in Astera Labs by 207.7% during the 2nd quarter. Harbour Investments Inc. now owns 2,446 shares of the company’s stock valued at $221,000 after purchasing an additional 1,651 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other Astera Labs news, CFO Michael Truett Tate sold 11,430 shares of the firm’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the transaction, the chief financial officer directly owned 192,297 shares of the company’s stock, valued at approximately $27,823,452.93. This trade represents a 5.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Manuel Alba sold 150,000 shares of the business’s stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $166.18, for a total value of $24,927,000.00. Following the sale, the director owned 1,574,498 shares of the company’s stock, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 576,936 shares of company stock valued at $87,409,540 in the last 90 days. Insiders own 12.50% of the company’s stock.

Astera Labs Trading Down 1.3%

NASDAQ:ALAB opened at $142.82 on Friday. The company has a market cap of $24.12 billion, a PE ratio of 128.67, a price-to-earnings-growth ratio of 1.97 and a beta of 1.50. The company has a 50 day simple moving average of $163.93 and a two-hundred day simple moving average of $172.64. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. During the same period last year, the business posted $0.23 EPS. The company’s revenue for the quarter was up 103.9% on a year-over-year basis. Research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on ALAB shares. BNP Paribas Exane started coverage on shares of Astera Labs in a report on Thursday, November 20th. They issued an “outperform” rating for the company. Barclays set a $165.00 price objective on shares of Astera Labs in a report on Thursday, January 15th. JPMorgan Chase & Co. increased their target price on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Needham & Company LLC boosted their price target on Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Finally, Citigroup reaffirmed an “outperform” rating on shares of Astera Labs in a report on Tuesday, December 9th. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $190.63.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.